Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (121-130 of 216) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|March 3, 2020
Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB ReceptorMaria T Georgescu, Paul C Moorehead, Tongyao Liu, et al.
Journal of Pediatric Hematology/Oncology|November 21, 2014
Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitorPaul C Moorehead, Lisa Thibeault, Angie Tuttle, et al.
Journal of Pediatric Hematology/Oncology|July 31, 2004
Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleedingIris Hedlund-Treutiger, Shoshana Revel-Vilk, Victor S Blanchette, et al.
Environmental Science & Technology|September 12, 2013
In vivo passive sampling of nonpolar contaminants in brown trout (Salmo trutta)Ian John Allan, Kine Bæk, Thrond Oddvar Haugen, et al.
Blood|November 6, 2007
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia ASrinivasa Prasad, David Lillicrap, Andrea Labelle, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2019
The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent mannerLaura L Swystun, Colleen Notley, Ilinca Georgescu, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2023
Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cellsMatthew Cormier, Erin Burnett, Aomei Mo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2020
von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced ObesityAlison Michels, Courtney N Dwyer, Jeffrey Mewburn, et al.
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Factor XIII deficiency due to compound heterozygosity for 2 <i>F13A1</i> variantsJodie Odame, Caroline Malcolmson, Cindy Wakefield, et al.
Blood|April 2, 2016
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia AJesse D Lai, Paul C Moorehead, Kate Sponagle, et al.
Pageof 22

Showing results (121-130 of 216) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|March 3, 2020
Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB ReceptorMaria T Georgescu, Paul C Moorehead, Tongyao Liu, et al.
Journal of Pediatric Hematology/Oncology|November 21, 2014
Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitorPaul C Moorehead, Lisa Thibeault, Angie Tuttle, et al.
Journal of Pediatric Hematology/Oncology|July 31, 2004
Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleedingIris Hedlund-Treutiger, Shoshana Revel-Vilk, Victor S Blanchette, et al.
Environmental Science & Technology|September 12, 2013
In vivo passive sampling of nonpolar contaminants in brown trout (Salmo trutta)Ian John Allan, Kine Bæk, Thrond Oddvar Haugen, et al.
Blood|November 6, 2007
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia ASrinivasa Prasad, David Lillicrap, Andrea Labelle, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2019
The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent mannerLaura L Swystun, Colleen Notley, Ilinca Georgescu, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2023
Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cellsMatthew Cormier, Erin Burnett, Aomei Mo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2020
von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced ObesityAlison Michels, Courtney N Dwyer, Jeffrey Mewburn, et al.
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Factor XIII deficiency due to compound heterozygosity for 2 <i>F13A1</i> variantsJodie Odame, Caroline Malcolmson, Cindy Wakefield, et al.
Blood|April 2, 2016
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia AJesse D Lai, Paul C Moorehead, Kate Sponagle, et al.
Pageof 22